Thumbi Ndung’u consults for Gilead Sciences, Inc. He has received HIV cure-related research grants from Gilead Sciences, Inc, the US NIH, Bill and Melinda Gates Foundation, Wellcome Trust and ...

For this study, Mona Bafadhel received funding from AstraZeneca to complete the study described ... For decades, the standard treatment for these potentially life-threatening episodes has remained ...

Multiple lanes of southbound Interstate 795 will close starting Wednesday for concrete pavement repairs. The Maryland State ...

Medically reviewed by William Truswell, MD Laser treatments are the most common option for rosacea, and they’re relatively ...

A phase 2 study for patients with HR-positive, HER2-negative metastatic breast cancer will be evaluating alisertib plus ...

SIDNEY — The Shelby County Common Pleas Court recently handed down several sentences for failure to provide change of address ...

The Iona Island Wastewater Treatment Plant project will expand the plant to meet projected population growth as well as ...

Meaningful change thresholds for the EORTC Quality of Life Questionnaire in chronic lymphocytic leukemia (CLL) or small ...

Colorado's second-highest court last week overturned a Jefferson County judge's decision that terminated a man's legal ...

Findings from the HELEN-006 trial suggest a potential shift in neoadjuvant treatment practices for patients with HER2-positive early breast cancer, specifically using nab-paclitaxel to reduce ...

Phase 2 data show about half of patients with high-risk or secondary acute myeloid leukemia achieved a complete response or ...

PRO® and Siemens Healthineers' Magnetom Free.Max - TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound” or the "Company”), a commercial-stage medical ...